|
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
|
15 September 2014 |
|
Oxidative damage to macromolecules in the thyroid - experimental evidence
|
11 September 2014 |
|
Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth
|
10 September 2014 |
|
Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction
|
08 September 2014 |
|
Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation--a systematic review and meta-analysis
|
08 September 2014 |
|
The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
|
01 September 2014 |
|
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives
|
29 August 2014 |
|
Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells
|
29 August 2014 |
|
Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1)
|
28 August 2014 |
|
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth
|
26 August 2014 |